![NeraCare Announces Strategic Partnership and Licensing Agreement with SkylineDx | American Laboratory NeraCare Announces Strategic Partnership and Licensing Agreement with SkylineDx | American Laboratory](https://media.americanlaboratory.com/m/20/article/596632.jpg)
NeraCare Announces Strategic Partnership and Licensing Agreement with SkylineDx | American Laboratory
![Biocartis on Twitter: "πποΈ Press news: Biocartis and @skylinedx π³π± πΊπΈ Sign Collaboration to Develop the #Merlin Assay, a Test Predicting Risk for Nodal Metastasis in #Melanoma, on #Idyllaβ’ π https://t.co/olwFTo0tR5 https://t.co/QPQS65kncL" / Biocartis on Twitter: "πποΈ Press news: Biocartis and @skylinedx π³π± πΊπΈ Sign Collaboration to Develop the #Merlin Assay, a Test Predicting Risk for Nodal Metastasis in #Melanoma, on #Idyllaβ’ π https://t.co/olwFTo0tR5 https://t.co/QPQS65kncL" /](https://pbs.twimg.com/media/Ezj0k6YXEAIXEPG.jpg)
Biocartis on Twitter: "πποΈ Press news: Biocartis and @skylinedx π³π± πΊπΈ Sign Collaboration to Develop the #Merlin Assay, a Test Predicting Risk for Nodal Metastasis in #Melanoma, on #Idyllaβ’ π https://t.co/olwFTo0tR5 https://t.co/QPQS65kncL" /
![SkylineDx awarded 'Best Molecular Diagnostics R&D Company β Europe' at the GHP Biotechnology Awards 2023 - Rotterdam Square SkylineDx awarded 'Best Molecular Diagnostics R&D Company β Europe' at the GHP Biotechnology Awards 2023 - Rotterdam Square](https://rotterdamsquare.nl/wp-content/uploads/2023/05/Skyline-Dx-Biotech-Awards-2023.jpg)